Weight-loss drugs linked to 30% lower breast cancer risk in large study

THE GUARDIAN

Three large studies found that women taking GLP-1 drugs such as Ozempic and Mounjaro were about 30% less likely to develop breast cancer. The drugs also slowed cancer progression across seven solid tumor types. Researchers cite reduced inflammation and improved metabolic health as likely factors.